Hypertension (HTN)NCT07760350
Assessing the Feasibility of the "Heart Care Pairs" Intervention
A study testing Dyadic lifestyle intervention for CVD risk reduction in people with Hypertension (HTN), run by University of Alabama at Birmingham at 1 site in United States.
Trial summary
The researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypertension (HTN)
- What is being tested?
- Dyadic lifestyle intervention for CVD risk reduction
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 85 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Nov 2026to 30 Jun 2027
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Diagnosed with hypertension and/or taking blood pressure lowering medications
- willing to invite a supportive partner to participate for the duration of the study including an enrollment and baseline measurement visit, up to 6 intervention visits, and a post-intervention measurement visit.
Who cannot join
- untreated serious mental illness or cognitive decline that would limit ability to provide informed consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Department of Family & Community Medicine; University of Alabama at Birmingham
Birmingham, Alabama, 35205
About this study
Official title: A Mixed Methods Pilot Feasibility Study of a Primary Care-based Dyadic Cardiovascular Risk Reduction Intervention: "Heart Care Pairs"
The researchers will invite 30 patients in primary care who have high blood pressure to participate in this health program with a supportive partner of their choosing (these will be the "participant pairs"). Participant pairs will be invited to complete the Heart Care Pairs health program that will include up to six sessions each including 1) some education on a health habit like physical activity and heart healthy foods, 2) goal setting together, and 3) talk about healthy communication to support one another with heart healthy habits. The researchers will work with participants to address things that get in the way of coming for visits like offering transportation and offering telehealth visits. The researchers are seeing how this program works in real life so participants will be asked to complete as many sessions as they want to and can attend. The researchers will be interested in what participants think about the sessions, if they were satisfied with the visits, and if they would recommend the program to others in their community. The researchers will ask these questions in interviews with participants. The researchers will also ask up to 25 primary care workers about how they view the program as helpful to their work with patients with high blood pressure and whether they would refer more patients to the program in the future.
Read the detailed description
The overall objective of the present pilot behavioral trial is to assess the feasibility and acceptability of a dyadic CVD risk reduction intervention to be delivered by behavioral health consultants in primary care practices for patients with HTN. In a preliminary investigation prior to this pilot project, the research team has confirmed feasibility of recruitment of dyads from primary care settings, assessed health and social support needs, and interest in an intervention like Heart Care Pairs while making ongoing systematic adaptations to the intervention. The next phase of pilot work outlined in this proposal will assess if the intervention will work in primary care by assessing retention, treatment process, and acceptability.
Aim 1: To determine the feasibility and acceptability of the Heart Care Pairs intervention with N=30 dyads including patients with HTN attending primary care and their chosen supportive partner using a mixed methods single-arm pragmatic trial.
Hyp 1: Heart Care Pairs will be feasible based on dyads attending <70% of intervention sessions, completion of follow-up assessments and interviews, and overall patient- and partner-reported satisfaction with the intervention.
Aim 2: To assess primary care workflow and PCP acceptability of making referrals to a dyadic behavioral health intervention.
Hyp 2: PCPs will agree that they referred patients to the Heart Care Pairs intervention and that the availability of the referral is helpful for their practice.
- Conditions
- Hypertension (HTN)
- Being tested
- Dyadic lifestyle intervention for CVD risk reduction
- Keywords
- hypertension, primary care, integrated behavioral health, dyadic intervention
- Medical subject headings
- Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Dyadic lifestyle intervention for CVD risk reductionBehavioural
This is a 6-session behavioral intervention delivered in primary care. The 6 educational topics include: 1) DASH diet; 2) Physical activity; 3) Stress management; 4) Healthy sleep habits; 5) Substance cessation (optional); 6) Adherence to medications and lifestyle habits. All sessions will include collaborative goal setting. And each educational topic will be paired with a communication skill: 1) Seeing others' perspectives; 2) Minimize efforts to control; 3) Non-judgmental language; 4) Support movement towards change; 5) Addressing relapse; and 6) Empathetic responding and self-advocacy.
| Study group | Role | What they receive |
|---|---|---|
| Intervention | Experimental | Dyadic lifestyle intervention for CVD risk reduction "Heart Care Pairs" Receives: Behavioral: Dyadic lifestyle intervention for CVD risk reduction |
What is being measured
The primary outcome is the main question the study is designed to answer.
Completion of follow-up assessments
Number of surveys and interviews completed
Measured: Immediately post-intervention
Time to complete recruitment
Time from posting recruitment materials to enrollment of 30 dyads
Measured: From study start to end of recruitment, an average of 6 months
Responsiveness to change on survey measures
Change scores between baseline assessment to follow-up assessment
Measured: Baseline to immediately post-intervention - approximately 12 weeks
Attendance to intervention sessions
Number of sessions attended compared to number of sessions missed
Measured: Baseline to immediately post-intervention - approximately 12 weeks
Treatment Satisfaction Questionnaire
Participant ratings of satisfaction with the HCPs intervention. 9-items, with responses on a scale from 1-7. Some items assess satisfaction (1=extremely dissatisfied to 7=extremely satisfied), confidence (1=not at all confident, 7=extremely confident, certainty (1=not at all certain, 7=extremely certain), how easy to use/do the intervention was (1=extremely difficult, 7=extremely easy). Mean scores will be calculated for min score=1 and max score of 7. Higher scores indicate greater satisfaction, and lower burden with the intervention.
Measured: Immediately post-intervention
Secondary outcomes (14)
Health-related quality of life (HRQoL)
1-item self-rated health status (Bullinger, 1996; Dumas, et al, 2020)
Measured: Baseline and immediately post-intervention
Perceived Stress Scale - 10
10-item Perceived Stress Scale (PSS-10; Roberti, et al, 2006). Responses range from 0=Never to 4=Very often. Scores are summed for total perceived stress score ranging from 0-40 with higher scores meaning higher perceived stress.
Measured: Baseline and immediately post-intervention
Smoking status
1-item cigarette smoking status and number cigarettes per day
Measured: Baseline and immediately post-intervention
Patient Health Questionnaire - 9
PHQ-9 depression screen (Kroenke, et al, 2001). Respondents endorse symptoms of depression over the past 2 weeks on a scale from 0=not at all to 3=nearly everyday. Scores are summed for total scores ranging from 0 to 27 with higher scores indicating greater severity of depression symptoms.
Measured: Baseline and immediately post-intervention
Generalized anxiety disorder (GAD)-7
GAD-7 screen for anxiety symptoms (Spitzer, et al., 2006). Respondents endorse symptoms of anxiety over the past 2 weeks on a scale from 0=not at all to 3=nearly everyday. Scores are summed for total scores ranging from 0 to 21 with higher scores indicating greater severity of anxiety symptoms.
Measured: Baseline and immediately pot-intervention
Body mass index
Approximation of body size based on clinic measured height and weight
Measured: Baseline and immediately post-intervention
Mediterranean Eating Pattern Assessment (MEPA)
Brief assessment of heart healthy eating, self-report recall for past week,16 items. Items assess self-reported number of servings per type of food in the past week. Items are scored based on thresholds meeting a mediterranean diet eating pattern (e.g., greater than or equal to 2 servings of vegetables per day). Scores range from 0-16 with higher scores being more adherent to mediterranean diet pattern (more heart healthy diet).
Measured: Baseline and immediately post-intervention
International physical activity questionnaire short form (IPAQ-SF)
Self-reported walking, moderate physical activity, vigorous physical activity, and sedentary time, 7-items (Lee, et al, 2011). Total met minutes are calculated for each activity domain. Walking MET minutes = 3.3*walking days* walking minutes. Moderate MET minutes = 4.0*moderate days*moderate minutes. Vigorous MET minutes=8.0*vigorous days*vigorous minutes. Total MET minutes = Waling MET min+Moderate MET min+Vigorous MET min.
Measured: Baseline and immediately post-intervention
Sleep time
1-item total average sleep time (Lloyd-Jones, et al, 2022)
Measured: Baseline and immediately post-intervention
Adherence self-report questionnaire (ASRQ)
Self reported medication adherence to blood pressure medicines (Zeller, et al., 2008) 1-item with 1=take all BP medications at the same time every day (excellent adherence) to 6=Hardly take any BP medications (poor adherence).
Measured: Baseline and immediately post-intervention
Treatment Self Regulation Questionnaire
Measure of autonomy, self-report 19-tems (Levesque, et al, 2007). 19-items assessed using a Likert-type scale from 1=Not at all true to 7=Very true. Mean of scores will be calculated with higher score meaning greater autonomy over heart healthy behaviors (taking medications, healthy diet, exercise).
Measured: Baseline and immediately post-intervention
Important other climate questionnaire
Measure of autonomy support, self-report 6-items (Williams, 2006). Responses are on a Likert Scale. Mean scores will be calculated with higher scores indicating greater support from "important others" with efforts to lower blood pressure.
Measured: Baseline and immediately post-intervention
Social Support for Diet and Exercise Behaviors
Social support from family, friends, supportive other related to healthy diet and exercise behavior (Sallis, et al., 1987). Responses range from 0=Rarely to 3=very often. Each question will be asked for "Family," "Friends," and "Study Partner." Mean scores for each relationship type will be calculated with higher scores indicate greater support with health behavior.
Measured: Baseline and immediately post-intervention
Medical Outcomes Study (MOS) Social Support Survey
A total of 19-items self-report for measures of global social support and subscales for: emotional/informational, tangible, affectionate, and positive social interaction. Responses to items range from 1=none of the time to 5=all of the time. The mean items responses are taken for each subscale with higher scores meaning greater social support (Sherbourne \& Stewart, 1991)
Measured: Baseline and immediately post-intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Aug 2026
- Study start1 Nov 2026 (estimated)
- Primary completion1 May 2027 (estimated)
- Study completion30 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hypertension (HTN)Studies of the same condition, open and under way.
- More trials run by University of Alabama at BirminghamThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- One armed behavioral pilot feasibility trial
- Masking
- None (open label)
- Enrolment
- 85 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Alabama at Birmingham
- Sponsor type
- University, hospital or other
- Collaborators
- National Institute on Minority Health and Health Disparities (NIMHD)
- Responsible party
- Principal investigator, Kaylee Crockett, University of Alabama at Birmingham
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07760350
- Sponsor's protocol ID
- IRB-300016958
- Other IDs
- P50MD017338
- Status last verified
- Aug 2026
- First submitted
- 24 Jul 2026
- Last updated
- 12 Aug 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided